Keeping Track: Entasis’ Antibiotic Xacduro, Two Opioid Misuse Therapies Clear US FDA; Pfizer’s Paxlovid Makes It Official

Infectious disease provided the backdrop for both of the US FDA’s novel approvals last week, one an antiviral and one an antibiotic.

The antiviral is already familiar to patients and prescribers. Pfizer Inc.’s COVID-19 therapeutic Paxlovid became on the top-selling drugs in the world while available under Emergency Use Authorization, but...